Yangjiong Xiao
Xian Central Hospital(CN)First Affiliated Hospital of Guangzhou Medical University(CN)State Key Laboratory of Respiratory Disease(CN)Southern Medical University(CN)East China Normal University(CN)University of Pennsylvania(US)Guangzhou Medical University(CN)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways, Cancer Mechanisms and Therapy, Genomics and Chromatin Dynamics
Most-Cited Works
- → The PI3K/mTOR dual inhibitor GSK458 potently impedes ovarian cancer tumorigenesis and metastasis(2020)36 cited
- → Inhibition of CDC25B With WG-391D Impedes the Tumorigenesis of Ovarian Cancer(2019)21 cited
- → RNF7 knockdown inhibits prostate cancer tumorigenesis by inactivation of ERK1/2 pathway(2017)20 cited
- → The Exocrine Differentiation and Proliferation Factor (EXDPF) Gene Promotes Ovarian Cancer Tumorigenesis by Up-Regulating DNA Replication Pathway(2021)12 cited
- Diverse effects of two kinds of PI3K inhibitors on drug-resistant human breast cancer MCF-7/MIT cells(2009)
- Cyclosporine A enhances autophagic cell death of malignant glioma U87-MG cells induced by arsenic trioxide.(2009)
- In vitro scavenging free radical and antioxidant effects of extracts from Myrtus communis Linn. leaves(2009)